Pivotal study enrolment has been paused while Biohaven characterises a metabolite of opakalim and its safety in humans.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results